SCHEMBL2185138

SCHEMBL2185138

CN1CCN(NC(=O)c2nn(-c3ccc(Cl)cc3Cl)c3c2CCOc2cc(Cl)ccc2-3)CC1

nearest known ligand 0.65

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 11/20 0.65
▸ CNR1 P21554 7/20 0.64
▸ TDP1 Q9NUW8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2186048 0.92 CNR2 (0.73) CNR2CNR1TDP1
SCHEMBL2185163 0.91 CNR2 (0.68) CNR2CNR1TDP1
SCHEMBL2186076 0.91 CNR2 (0.74) CNR2CNR1TDP1
SCHEMBL2186833 0.88 CNR2 (0.72) CNR2CNR1TDP1
SCHEMBL2187202 0.87 CNR2 (0.73) CNR2CNR1TDP1
SCHEMBL2186051 0.85 CNR2 (0.68) CNR2CNR1TDP1
SCHEMBL2185805 0.85 CNR1 (0.63) CNR2CNR1
SCHEMBL14746852 0.84 CNR2 (0.77) CNR2CNR1TDP1
SCHEMBL2492413 0.82 CNR2 (0.52) CNR2CNR1
SCHEMBL16161285 0.82 CNR2 (0.59) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030345-B2 Tricyclic pyrazole derivatives as cannabinoid receptor modulators CADILA HEALTHCARE LIMITED (IN) 2011-10-04 — — US claimed
EP-2343302-A1 TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CADILA HEALTHCARE LIMITED (IN) 2011-07-13 — — EP claimed
US-8030345-B2 Tricyclic pyrazole derivatives as cannabinoid receptor modulators CADILA HEALTHCARE LIMITED (IN) 2011-10-04 — — US disclosed
EP-2343302-A1 TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS CADILA HEALTHCARE LIMITED (IN) 2011-07-13 — — EP disclosed
Send feedback